latest news in companies
Johnson & Johnson Faces New Legal Pressure as Judge Admits Cancer Evidence
New Brunswick, Thursday, 22 January 2026.
A special master’s recommendation now permits expert testimony linking talc to ovarian cancer, a critical procedural shift affecting over 67,500 lawsuits despite Johnson & Johnson’s immediate appeal plans.
Axogen Upsizes Stock Offering to $124 Million to Clear Debt and Fund Growth
Tampa, Thursday, 22 January 2026.
Axogen, Inc. has significantly expanded its capital raising targets, pricing an upsized public offering at $124 million—far exceeding the initially proposed $85 million. The biotechnology leader in peripheral nerve repair priced 4 million shares at $31.00 each, aiming to utilize the proceeds for the early repayment of its Oberland Capital debt and to fund general corporate growth. While this substantial capital injection streamlines the company’s balance sheet, the immediate market response saw shares slip in after-hours trading. This financing follows the company’s recent FDA approval for its Avance nerve graft, signaling a strategic pivot toward aggressive operational scaling despite short-term stock volatility.
Lucid Group Stock Surges as Major Saudi Backer Reaffirms Long-Term Financial Support
Newark, Thursday, 22 January 2026.
Cantor Fitzgerald’s confirmation of Saudi Arabia’s continued backing drove a 15% rally, a critical lifeline for Lucid given the sovereign wealth fund already owns a controlling 50% stake.
CoreWeave Investors Initiate Legal Action After Data Center Delays Trigger $14 Billion Valuation Collapse
San Francisco, Wednesday, 21 January 2026.
Cloud infrastructure provider CoreWeave is facing a wave of securities class action lawsuits alleging the company misled shareholders regarding critical infrastructure delays. The central controversy involves the Denton, Texas data center—a key facility intended for OpenAI—where construction setbacks reportedly existed months before public disclosure. While CoreWeave management attributed lowered revenue guidance to temporary third-party issues in November 2025, subsequent reports indicate that development partner Core Scientific had flagged these delays as early as February 2025. This significant transparency gap precipitated a severe volatility event, erasing approximately $14 billion in market capitalization between November and December 2025. Investors are now scrutinizing whether the firm intentionally overstated its operational capacity to protect its stock price following its March 2025 IPO.
Paramount Introduces Automated Ad Buying for Live Sports Starting with UFC
New York, Wednesday, 21 January 2026.
On January 24, Paramount initiates real-time automated ad buying for live sports. Debuting with UFC, this marks the first time marketers can secure guaranteed programmatic spots in premium streaming coverage.
